Project details
- Project period
- 1 Dec 2024 - 30 Nov 2028
- Total cost
- €5 736 729,64
- Global Health EDCTP3 funding
- €5 736 729,64
- Call identifier
- HORIZON_HORIZON-JU-GH-EDCTP3-2023-02-01-two-stage
- Status
- In progress
- Project type
- Research and Innovation Actions (RIA)
- Disease area
- Malaria
- Intervention type
- Vaccines
Consortium map
Coordinator
R-EVOLUTION WORLDWIDE SRL - IMPRESA SOCIALE
- Location
- MAGLIE, Italy
- EU contribution
- €296 437,50
- Total cost
- €296 437,50
Beneficiaries
UNIVERSITE DES SCIENCES DES TECHNIQUES ET DES TECHNOLOGIES DE BAMAKO
- Location
- Bamako, Mali
- EU contribution
- €1 932 071,25
- Total cost
- €1 932 071,25
EPICENTRE
- Location
- Paris, France
- EU contribution
- €1 469 570,89
- Total cost
- €1 469 570,89
CENTRE NATIONAL DE RECHERCHE SCIENTIFIQUE ET TECHNOLOGIQUE*INSTITUT DE RECHERCHE EN SCIENCES DE LA SANTE
- Location
- Ouagadougou, Burkina Faso
- EU contribution
- €2 038 650,00
- Total cost
- €2 038 650,00
Partners
LIVERPOOL SCHOOL OF TROPICAL MEDICINE
- Location
- LIVERPOOL 3, United Kingdom
Related projects
Advancing ‘triple therapy’ for malariaThe EDCTP2-funded ASAAP study has received additional Global Health EDCTP3 funding to complete its evaluation of a novel ‘triple therapy’ for malaria.
Tackling severe malaria in remote locationsThe SEMA ReACT study will determine whether children with severe malaria can be treated entirely in the community, when transportation to health...
AI detection of parasite infectionsThe MultiplexAI project is developing an easy-to-use add-on for conventional microscopes that deploys artificial intelligence (AI) models to detect...